Solchenberger, H.; Odendahl, M.; Schriefer, D.; Proschmann, U.; Rahbani, G.K.a.; Ziemssen, T.; Akgün, K.
Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs. Pathogens 2025, 14, 235.
https://doi.org/10.3390/pathogens14030235
AMA Style
Solchenberger H, Odendahl M, Schriefer D, Proschmann U, Rahbani GKa, Ziemssen T, Akgün K.
Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs. Pathogens. 2025; 14(3):235.
https://doi.org/10.3390/pathogens14030235
Chicago/Turabian Style
Solchenberger, Hannah, Marcus Odendahl, Dirk Schriefer, Undine Proschmann, Georges Katoul al Rahbani, Tjalf Ziemssen, and Katja Akgün.
2025. "Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs" Pathogens 14, no. 3: 235.
https://doi.org/10.3390/pathogens14030235
APA Style
Solchenberger, H., Odendahl, M., Schriefer, D., Proschmann, U., Rahbani, G. K. a., Ziemssen, T., & Akgün, K.
(2025). Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs. Pathogens, 14(3), 235.
https://doi.org/10.3390/pathogens14030235